Literature DB >> 2143707

Decreased serum levels of IgE and IgE-binding factors in individuals infected with HTLV-I.

T Matsumoto1, T Miike, K Mizoguchi, K Yamaguchi, K Takatsuki, M Hosoda, T Kawabe, J Yodoi.   

Abstract

The cell surface expression of low-affinity Fc epsilon receptor (Fc epsilon RII), which is identical to CD23, and the serum levels of IgE binding factors (IgE BFs), a soluble form of Fc epsilon RII, and IgE were investigated in HTLV-I-infected individuals, and the results were compared with those for HTLV-I-negative controls. The occurrence of Fc epsilon RII+ mononuclear cells did not differ among the blood samples from the HTLV-I-infected groups; however, the levels of serum IgE BFs were significantly decreased (P less than 0.001) in patients with adult T cell leukaemia (ATL), compared with HTLV-I-negative controls. The serum IgE levels were also significantly decreased in these groups, including cases of ATL (P less than 0.001) and HTLV-I-associated myelopathy (P less than 0.05), and HTLV-I carriers (P less than 0.05), as compared with HTLV-I-negative controls. Since cases of strongyloidiasis or filariasis are frequently found among HTLV-I-infected individuals in Japan, these results may explain in part their defective defence mechanisms for parasites. The possible involvement of IgE BFs in the development of immune deficiency state in HTLV-I infection is also discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143707      PMCID: PMC1535034          DOI: 10.1111/j.1365-2249.1990.tb03319.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  T-cell-derived IgE-binding factors. I. Cloned and transformed T cells producing IgE-binding factors.

Authors:  T B Nutman; G Delespesse; M Sarfati; D J Volkman
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

2.  Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia.

Authors:  K Shirono; T Hattori; H Hata; H Nishimura; K Takatsuki
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

3.  Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.

Authors:  T Kawabe; M Takami; M Hosoda; Y Maeda; S Sato; M Mayumi; H Mikawa; K Arai; J Yodoi
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

4.  Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1971-12

5.  Effect of immunosuppressive factors produced by adult T cell leukemia cells on B cell responses.

Authors:  Y Tanaka; F Shirakawa; S Oda; S Chiba; H Suzuki; S Eto; U Yamashita
Journal:  Jpn J Cancer Res       Date:  1987-12

6.  Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis.

Authors:  K Nakada; K Yamaguchi; S Furugen; T Nakasone; K Nakasone; Y Oshiro; M Kohakura; Y Hinuma; M Seiki; M Yoshida
Journal:  Int J Cancer       Date:  1987-08-15       Impact factor: 7.396

7.  Participation of IL-4 in the formation of IgD-binding factors by antigen-primed mouse spleen cells.

Authors:  M Adachi; N Arai; K Ishizaka
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Formation of IgE-binding factors by T cells of patients infected with human immunodeficiency virus type 1.

Authors:  C Carini; J Margolick; J Yodoi; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).

Authors:  G Delespesse; M Sarfati; R Peleman
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

10.  The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.

Authors:  S Swendeman; D A Thorley-Lawson
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more
  5 in total

1.  Strongyloidiasis.

Authors:  R G Shidrawi; D Westaby
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

2.  Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica.

Authors:  O Adedayo; G Grell; P Bellot
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

3.  Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.

Authors:  Brenda M Birmann; Elizabeth C Breen; Sherri Stuver; Beverly Cranston; Otoniel Martínez-Maza; Kerstin I Falk; Akihiko Okayama; Barrie Hanchard; Nancy Mueller; Michie Hisada
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

4.  Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases.

Authors:  T Matsumoto; T Miike; K Yamaguchi; M Murakami; T Kawabe; J Yodoi
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia.

Authors:  Lee Ratner; Christian Grant; Bevin Zimmerman; Joseph Fritz; Gary Weil; Alex Denes; Rama Suresh; Nancy Campbell; Steve Jacobson; Michael Lairmore
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.